News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
634,695 Results
Type
Article (66733)
Company Profile (103)
Press Release (567850)
Multimedia
Podcasts (208)
Webinars (30)
Section
Business (184854)
Career Advice (2540)
Deals (29296)
Drug Delivery (228)
Drug Development (74161)
Employer Resources (165)
FDA (16651)
Job Trends (12892)
News (288296)
Policy (30807)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Standard (4)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (2938)
Academic (1)
Accelerated approval (77)
ADA (49)
Adcomms (44)
Allergies (221)
Alliances (40009)
ALS (274)
Alzheimer's disease (2071)
Antibody-drug conjugate (ADC) (698)
Approvals (17192)
Artificial intelligence (925)
ASCO (320)
Autoimmune disease (499)
Automation (68)
Bankruptcy (326)
Belgium (44)
Best Places to Work (9806)
BIO (70)
Biologics (110)
Biomarkers (1)
BIOSECURE Act (23)
Biosimilars (284)
BioSpace Insights (173)
Biotechnology (65)
Bispecific (61)
Bladder cancer (241)
Brain cancer (98)
Breast cancer (896)
Cancer (7483)
Cardiovascular disease (644)
Career advice (2198)
Career pathing (60)
CAR-T (403)
CDC (82)
CDMO (213)
Celiac Disease (5)
Cell-line development (2)
Cell therapy (1111)
Cervical cancer (63)
Clinical research (66366)
Collaboration (2412)
Commercialization (65)
Company closure (9)
Compensation (1872)
Complete response letters (128)
COVID-19 (2899)
CRISPR (143)
CRO (8)
C-suite (1599)
Cystic fibrosis (171)
Data (10537)
Decentralized trials (4)
Denatured (54)
Depression (220)
Dermatology (194)
Diabetes (775)
Diagnostics (6485)
Digital health (65)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (431)
Drug pricing (249)
Drug shortages (36)
Duchenne muscular dystrophy (377)
Earnings (67574)
Editorial (85)
Employer branding (22)
Employer resources (152)
ESMO (401)
Events (92594)
Executive appointments (1260)
Eye disease (26)
FDA (21587)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (38)
Funding (2078)
Gene editing (293)
Generative AI (83)
Gene therapy (899)
GLP-1 (1324)
Government (4540)
Grass and pollen (8)
Guidances (428)
Healthcare (16731)
Hematology (225)
HIV (117)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (15)
IgA nephropathy (153)
Immunology and inflammation (416)
Immuno-oncology (146)
Indications (280)
Infectious disease (3315)
Inflammatory bowel disease (262)
Inflation Reduction Act (14)
Influenza (151)
Intellectual property (364)
Interviews (478)
IPO (14494)
IRA (58)
Job creations (3296)
Job search strategy (1769)
JPM (69)
Kidney cancer (31)
Kidney disease (173)
Labor market (135)
Layoffs (691)
Leadership (68)
Legal (7221)
Licensing (124)
Liver cancer (116)
Longevity (45)
Lung cancer (1027)
Lung diease (26)
Lymphoma (547)
Machine learning (72)
Management (57)
Manufacturing (1404)
Marketing (41)
MASH (248)
Medical affairs (6)
Medical device (12648)
Medtech (12938)
Melanoma (220)
Mergers & acquisitions (16200)
Metabolic disorders (2029)
Middle East (2)
mRNA (321)
Multiple sclerosis (234)
Multispecific (7)
NASH (23)
Netherlands (40)
Neurodegenerative disease (598)
Neuropsychiatric disorders (148)
Neuroscience (4131)
Neurotech (4)
NextGen: Class of 2026 (5474)
Non-profit (3865)
Now hiring (53)
Obesity (980)
Opinion (348)
Ovarian cancer (279)
Pain (319)
Pancreatic cancer (440)
Parkinson's disease (466)
Partnered (39)
Patents (753)
Patient advocacy (6)
Patient recruitment (912)
Patient selection (116)
Peanut (77)
People (55175)
Peptides (40)
Pharmaceutical (27)
Pharmacy benefit managers (41)
Phase 1 (20011)
Phase 2 (28873)
Phase 3 (22968)
Pipeline (13809)
Policy (422)
Postmarket research (2578)
Preclinical (8622)
Press Release (48)
Prostate cancer (400)
Psychedelics (100)
Radioligand (3)
Radiopharmaceuticals (389)
Rare diseases (1543)
Real estate (4808)
Recruiting (70)
Regenerative medicine (38)
Regulatory (26380)
Reports (64)
Research institute (2486)
Resumes & cover letters (417)
Rett syndrome (59)
RNA editing (35)
RSV (93)
Saudi Arabia (1)
Schizophrenia (224)
Series A (350)
Series B (256)
Series C (1)
Service/supplier (8)
Sickle cell disease (148)
Special edition (35)
Spinal muscular atrophy (176)
Sponsored (58)
Startups (3145)
State (1)
Stem cells (7)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (156)
Switzerland (24)
Tariffs (109)
Tax incentives (2)
The Weekly (152)
Vaccines (1372)
Venture capital (181)
Weight loss (662)
Wet AMD (8)
Women's health (166)
Women in leadership (2)
Worklife (28)
Date
Today (133)
Last 7 days (773)
Last 30 days (3654)
Last 365 days (30103)
2026 (27569)
2025 (29090)
2024 (32485)
2023 (36511)
2022 (47006)
2021 (50701)
2020 (48089)
2019 (39462)
2018 (29781)
2017 (29980)
2016 (28527)
2015 (31306)
2014 (24863)
2013 (21723)
2012 (23010)
2011 (23099)
2010 (21364)
Location
Africa (816)
Alabama (96)
Alaska (7)
Arizona (386)
Arkansas (15)
Asia (37460)
Australia (7027)
California (15868)
Canada (3798)
China (1642)
Colorado (652)
Connecticut (714)
Delaware (489)
Europe (93262)
Florida (2453)
Georgia (502)
Hawaii (5)
Idaho (48)
Illinois (1265)
India (119)
Indiana (640)
Iowa (34)
Japan (739)
Kansas (132)
Kentucky (51)
Louisiana (49)
Maine (89)
Maryland (1876)
Massachusetts (11362)
Michigan (352)
Minnesota (837)
Mississippi (6)
Missouri (167)
Montana (15)
Nebraska (24)
Nevada (182)
New Hampshire (69)
New Jersey (4222)
New Mexico (24)
New York (4090)
North Carolina (1983)
North Dakota (13)
Northern California (8320)
Ohio (471)
Oklahoma (24)
Oregon (41)
Pennsylvania (2925)
Puerto Rico (30)
Rhode Island (48)
South America (1171)
South Carolina (100)
South Dakota (2)
Southern California (6326)
Tennessee (252)
Texas (2552)
United States (55140)
Utah (398)
Vermont (1)
Virginia (399)
Washington D.C. (77)
Washington State (1208)
West Virginia (4)
Wisconsin (163)
Wyoming (4)
634,695 Results for "queen s university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 Gangliosidoses
August 18, 2026
·
4 min read
Business
Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)
Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics.
April 10, 2023
·
5 min read
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
Press Releases
Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization
July 21, 2026
·
5 min read
Diabetes
Lilly’s retatrutide trounces Novo’s Ozempic in diabetes, weight loss
Eli Lilly’s next-gen weight loss drug retatrutide soundly beat Novo’s approved medicine Ozempic in weight loss and blood sugar reduction, padding the case for a regulatory application that’s expected in the first quarter of 2027.
October 28, 2026
·
3 min read
·
Annalee Armstrong
Podcast
Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
The FDA declined to approve Summit Therapeutics’ Akeso-partnered ivonescimab, putting other PD-1/VEGF drug developers on notice; Isomorphic bagged a $5 billion series C, the largest in biotech history; ObesityWeek and Clinical Trials on Alzheimer’s Disease conferences in full swing.
November 18, 2026
·
2 min read
·
Jef Akst
Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System
Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System.
September 27, 2022
·
7 min read
Alzheimer’s disease
CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
At the 2026 Clinical Trials on Alzheimer’s Disease conference, AriBio reported that AR1001 slowed cognitive decline more than placebo in patients not taking other drugs for the disease.
November 17, 2026
·
3 min read
·
Nick Paul Taylor
Alzheimer’s disease
Actinogen’s sole drug fails pivotal Alzheimer’s study, sinking stock 80%
Actinogen Medical’s lead program for its sole pipeline candidate has failed a late-stage study, but the Australian biotech still plans on taking the findings to the FDA for a path forward.
November 19, 2026
·
1 min read
·
Gabrielle Masson
Manufacturing
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
The
BioSpace
40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.
November 6, 2026
·
4 min read
·
Gabrielle Masson
1 of 63,470
Next